论文部分内容阅读
目的 :探讨糖尿病与抑郁症的关系及抗抑郁药对其的疗效。糖尿病病人也和许多内科疾病一样 ,易患抑郁、焦虑等情感性精神障碍。新型选择性 5 -HT再摄取抑制剂 (SSRIS、百优解 )因同时改善血糖而成为糖尿病病人的首选抗抑郁药。方法 :对 2 0例糖尿病合并抑郁症患者均在原有糖尿病治疗的基础上加用 5 -羟色胺再摄取制剂———盐酸氟西汀 (百优解 )剂量 2 0mg 日晨服 ,疗程 8周。观察疗效。结果 :糖尿病患者易患抑郁症 ,单一用降血糖药物治疗效果不明显者加用抗抑郁药物治疗有效。盐酸氟西汀 (百优解 )抗抑郁症疗效确切 ,副作用小 ,安全性高 ,服用方便。结论 :糖尿病抑郁症与精神心理因素相关 ,普遍存在抑郁和焦虑情绪 ,用抗焦虑药治疗能显著改善精神和躯体两方面症状
Objective: To investigate the relationship between diabetes mellitus and depression and the effect of antidepressants on them. Diabetic patients, like many medical conditions, are also susceptible to emotional disorders such as depression and anxiety. Novel selective 5-HT reuptake inhibitors (SSRIS, Baiyou Xie) as the first choice of antidepressants in patients with diabetes by improving blood sugar. Methods: Twenty patients with diabetes mellitus and depression were treated with 5 - hydroxytryptamine reuptake preparation (Fluoxetine Hydrochloride 100 mg daily) on the basis of the original diabetes mellitus for 8 weeks. Observe the effect. Results: Patients with diabetes predisposed to depression, single hypoglycemic agents with insignificant treatment plus antidepressants were effective. Fluoxetine hydrochloride (Baiyou Xie) antidepressant effective, side effects, high safety, easy to take. Conclusions: Depression in diabetes mellitus is associated with mental and psychiatric factors, and depression and anxiety are common. Treatment with anti-anxiety drugs can significantly improve both mental and physical symptoms